tiprankstipranks
Advertisement
Advertisement
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe FlyHemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
17d ago
uniQure put volume heavy and directionally bearish
Premium
The Fly
uniQure put volume heavy and directionally bearish
20d ago
uniQure put volume heavy and directionally bearish
Premium
The Fly
uniQure put volume heavy and directionally bearish
22d ago
uniQure upgraded to Outperform from Neutral at Mizuho
PremiumThe FlyuniQure upgraded to Outperform from Neutral at Mizuho
2M ago
uniQure upgraded at Mizuho on potential improvement in regulatory outlook
Premium
The Fly
uniQure upgraded at Mizuho on potential improvement in regulatory outlook
2M ago
uniQure: Regulatory Shift and AMT-130 Outlook Drive Reaffirmed Buy Rating and $70 Target
Premium
Ratings
uniQure: Regulatory Shift and AMT-130 Outlook Drive Reaffirmed Buy Rating and $70 Target
2M ago
Wells gives uniQure second upgrade on Prasad FDA departure
PremiumThe FlyWells gives uniQure second upgrade on Prasad FDA departure
2M ago
uniQure upgraded to Overweight from Equal Weight at Wells Fargo
Premium
The Fly
uniQure upgraded to Overweight from Equal Weight at Wells Fargo
2M ago
uniQure upgraded to Outperform from Sector Perform at RBC Capital
Premium
The Fly
uniQure upgraded to Outperform from Sector Perform at RBC Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100